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Constitutive activation of protein kinase B and phosphorylation
of p47phox by a membrane-targeted phosphoinositide 3-kinase
Svetlana A. Didichenko*, Bettina Tilton*, Brian A. Hemmings†, 
Kurt Ballmer-Hofer† and Marcus Thelen*
Background: Phosphoinositide 3-kinase (PI 3-kinase) activity is required for
mitogenic signaling and for secretory responses. Cell activation is presumed to
cause the translocation of PI 3-kinase from the cytosol to the plasma membrane
where the kinase interacts with its substrate phosphatidylinositol
(4,5)-bisphosphate. Thus, a membrane-targeted and therefore constitutively
active kinase could help elucidate the role of PI 3-kinase in intracellular signaling.
Results: The membrane-targeting sequence of Ha-Ras, containing the
consensus sequence for palmitoylation and farnesylation, was fused to the
carboxyl terminus of p110a, the catalytic subunit of PI 3-kinase. The lipid anchor
directed PI 3-kinase to the membrane and led to constitutively elevated
phosphatidylinositol (3,4,5)-trisphosphate levels in transfected cells. Expression
of membrane-targeted PI 3-kinase resulted in the continuous activation of
downstream effectors, such as protein kinase B (PKB, also known as Akt/RAC),
which was recently shown to regulate glycogen synthase kinase-3. The
constitutive activation of PKB was abolished by the specific PI 3-kinase inhibitor
wortmannin, and PKB activation was marginal in transfectants expressing non-
membrane-targeted PI 3-kinase. Multiple phosphorylation of the cytosolic factor
p47phox is required for the rapid assembly of the phagocyte NADPH oxidase
upon stimulation with agonists of G-protein-coupled receptors. We show here
that the expression of membrane-targeted PI 3-kinase in the monoblastic cell line
GM-1 results in a wortmannin-sensitive continuous phosphorylation of p47phox.
Conclusions: Targeting of PI 3-kinase to the site of its preferred substrate leads
to constitutive stimulus-independent enhanced catalysis and is sufficient to
regulate different signal transduction pathways.
Background
Phosphoinositide 3-kinase (PI 3-kinase) selectively phos-
phorylates the 3-OH position of phosphoinositides. The
enzyme has been implicated in mitogenic signal transduc-
tion induced by growth factors [1–6] and in the regulated
exocytosis of secretory organelles [7–10]. In resting cells,
the majority of PI 3-kinase is associated with the cytosol,
from where it has been purified as highly active enzyme
[10–12]. Interaction of the cytosolic protein with cellular
membranes has been suggested to be necessary for signal
transduction initiated by receptor agonists. Stimulation of
cells with platelet-derived growth factor (PDGF) causes
autophosphorylation of tyrosine residues of the cytoplas-
mic domain of the PDGF receptor, which serve as docking
sites for proteins containing Src homology 2 (SH2) domains
[13]. It is assumed that PI 3-kinase (p85/p110) is recruited
to the plasma membrane by the SH2 domains of p85
[6,13]. The receptor-associated kinase is then in close
vicinity with its substrate, phosphatidylinositol (4,5) bis-
phosphate (PI(4,5)-P2) and generates phosphatidylinositol
(3,4,5) trisphosphate (PI(3,4,5)-P3) [1]. Interactions between
proteins and membranes can be accomplished by attach-
ing lipid moieties to amino-acid sequences that contain
signals for myristoylation or farnesylation [14–16]. Fusion
of such consensus sequences to otherwise cytosolic proteins
has been used to generate membrane-associated proteins
and to study their stimulus-independent roles in signal
transduction [17,18].
The serine/threonine protein kinase B (PKB, also known
as Akt/RAC [19]) phosphorylates glycogen synthase
kinase-3, an enzyme which is involved in the regulation of
several physiological processes, including transcription
and glycogen and protein synthesis [20]. Activation of
PKB by growth factors is dependent on PI 3-kinase
[20–22]. Pretreatment of cells with the specific PI 3-kinase
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inhibitor wortmannin [8,10], or mutation of tyrosine
residues 740 and 751 of the PDGF receptor (the binding
sites for the SH2 domains of p85 [13]) blocks the activation
of PKB [20,21,23].
The NADPH oxidase of phagocytes is rapidly assembled
at the plasma membrane upon stimulation with G-protein-
coupled receptor agonists [24]. The assembly is accompa-
nied by the multiple phosphorylation of the cytosolic
factor p47phox [25,26]. Several protein kinases — including
ERK (extracellular signal-regulated kinase; [27,28]),
protein kinase C [28,29], protein kinase A [28,30] and
p21rac-activated kinase (PAK; [31]) — have been sug-
gested to phosphorylate p47phox at distinct sites.
PI 3-kinase has also been implicated in the regulation of
ERKs; [2,4,32,33] and the activation of p21rac [34]. Previ-
ous work has shown that wortmannin inhibits the activa-
tion of the NADPH oxidase by G-protein-coupled
receptor agonists [10,35].
We show here that expression of a membrane-targeted
PI 3-kinase causes constitutively elevated PI(3,4,5)-P3
levels in the corresponding transfectants. We found that the
outcome of the elevated PI(3,4,5)-P3 levels is the stimulus-
independent activation of PKB and a decrease in the basal
activity of ERKs. In addition, in the monoblastic phagocyte
cell line GM-1 [36], the elevated PI(3,4,5)-P3 levels correlate
with an enhanced basal phosphorylation of p47phox.
Results and discussion
In order to study the role of PI 3-kinase in signal transduc-
tion, we introduced a plasmid encoding a constitutively
active kinase that contained the membrane-targeting
sequence of Ha-Ras [16] into mammalian cells. The
CAAX motif (where C is cysteine, A is generally an
aliphatic amino acid and X is any amino acid) at the car-
boxyl terminus of Ras-like GTPases has been found to
determine the farnesylation of proteins. We therefore
fused 18 amino acids from the carboxyl terminus of
Ha-Ras (NPPDESGPGCMSCKCVLS; the CAAX
sequence is underlined) which specify farnesylation and
palmitoylation [16,18] to the carboxyl terminus of human
p110a (the catalytic subunit of PI 3-kinase) tagged with a
hemagglutinin (HA) epitope to produce the construct des-
ignated HA-p110CAAX. Membrane and cytosol fractions
were prepared from the monoblastic cell line GM-1 [36]
and from GM-1 cells transfected with HA-p110CAAX
(GM-128 cells). Western blot analysis using antibodies
directed against p85, the regulatory subunit of PI 3-kinase
(Fig. 1a), revealed that more than 90 % of the total
PI 3-kinase resided in the cytosol, and only a minor portion
was membrane-associated (Fig. 1a, left panel). The mar-
ginal increase of membrane-associated PI 3-kinase in
GM-128 cells suggests a moderate expression of mem-
brane-targeted PI 3-kinase (see below). By contrast, anti-
HA immunoprecipitation experiments revealed that about
50 % of the p85–HA-p110CAAX PI 3-kinase was mem-
brane-associated (Fig. 1a, right panel). The amount of p85
recovered in the anti-HA immunoprecipitates was small
compared with the total p85 precipitated with anti-p85
antibodies from identical fractions.
Activity measurements of anti-p85 immunoprecipitates
from parental and GM-128 cells confirmed that more than
95 % of total PI 3-kinase resided in the cytosol. However,
selective immunoprecipitation of the membrane-targeted
HA-tagged enzyme revealed that more than 50 % of the
PI 3-kinase activity was membrane-associated (Fig. 1b).
The PI 3-kinase activity which was immunoprecipitated
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Figure 1
The effect of membrane-targeting on the subcellular localization of
PI 3-kinase. (a) Western blots using polyclonal anti-p85 antibodies
(WB anti-p85). Left panel: cytosol (C) and membrane (M) fractions
from GM-1 cells and GM-128 cells (which continuously express
HA-p110CAAX); middle panel: immunoprecipitation from cytosol and
membrane fractions prepared from 3 × 106 GM-1 and GM-128 cells
with anti-p85 antibodies (IP p85); right panel: immunoprecipitations
from 7 × 106 GM-1 and GM-128 cells using an anti-HA monoclonal
antibody (IP HA). (b,c) PI 3-kinase activity in cytosol and membrane
fractions prepared from (b) GM-1 and GM-128 cells, and from (c)
NIH-3T3 fibroblasts transiently transfected with constructs expressing
wild-type p110 (HA-p110) or HA-p110CAAX. In (b) and (c), the
results shown are mean values ± SD of at least three independent
determinations.
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with anti-p85 antibodies was similar in GM-1 and
GM-128 cells (data not shown). Together with the results
shown in Figure 1, this observation indicates that the
expression of HA-p110CAAX does not cause a substantial
increase in the total PI 3-kinase pool. Accordingly, the
expression of membrane-targeted PI 3-kinase in GM-128
cells appeared not to affect the cytosol–membrane distrib-
ution of the total PI 3-kinase activity (as assessed in
anti-p85 immunoprecipitates).
We measured the PI 3-kinase activity in Saccharomyces cere-
visiae cells expressing the wild–type p85–HA-p110 and
p85–HA-p110CAAX constructs. Similar activities were
found in anti-p85 and anti-HA immunoprecipitates, sug-
gesting that the lipid anchor had no effect on the catalytic
activity (data not shown).
Cytosol and membrane fractions of NIH-3T3 fibroblasts
transiently transfected with wild type HA-p110 and with
HA-p110CAAX were assayed for PI 3-kinase activity. We
measured the total kinase activity in both subcellular com-
partments in anti-p85 immunoprecipitates, and confirmed
the prominent cytosolic location of the endogenous
enzyme. In contrast, about 70 % of anti-HA-precipitable
PI 3-kinase activity was recovered from the cytosol of cells
expressing HA-p110, whereas in cells expressing
HA-p110CAAX, about 75 % of the kinase activity was mem-
brane-associated (Fig. 1c). A similar distribution was found
in subcellular fractions prepared from S. cerevisiae co-trans-
formed with p85 and either of the two p110 constructs (data
not shown). Thus, membrane-targeted HA-p110CAAX
preferentially localizes to cellular membranes and confers
PI 3-kinase activity.
Figure 2 shows that membrane-targeted PI 3-kinase
constitutively increased the cellular content of PI(3,4,5)-P3
in serum-starved unstimulated GM-128 cells. The two-
fold increase in the PI(3,4,5)-P3 content of the transfec-
tants corresponds to the moderate expression of the
membrane-targeted PI 3-kinase. In resting cells, the
predominant phosphoinositide is PI(4,5)-P2, whereas the
content of 3-phosphorylated phosphoinositides is marginal
[37,38]. Comparison of the levels of PI(3,4,5)-P3 with
those of PI(4,5)-P2 showed that the PI(4,5)-P2 con-
centrations were similar in parental and transfected lines
(data not shown), and confirmed the small but significant
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Figure 2
Expression of membrane-targeted PI 3-kinase
results in constitutively elevated PI(3,4,5)-P3
levels. Serum-starved GM-1 and GM-128 cells
were labeled with 0.2 mCi ml–1
[32P]orthophosphate and then treated for
20 min with dialyzed 10 % fetal calf serum
(FCS; closed bars) or medium (open bars).
Reactions were then quenched and the
phosphoinositides were extracted. (a)
PI(3,4,5)-P3 content of control and serum-
stimulated cells. (b) Ratio of PI(3,4,5)-P3 to
PI(4,5)-P2 in resting (serum-starved) cells. (c)
Differences in the PI(3,4,5)-P3 content of
GM-128 and GM-1 cells. (d) Serum-stimulated
increase in PI(3,4,5)-P3 content in GM-1 and
GM-128 cells. (e) Typical autoradiogram of a
thin layer chromatography (TLC) plate used to
calculate PI(3,4,5)-P3 and PI(4,5)-P2 contents.
(f) High performance liquid chromatography
(HPLC) traces of deacylated phosphoinositides
(GroPIns(4,5)-P2, GroPIns(3,4,5)-P3) prepared
from serum-starved GM-1 (circles) and
GM-128 (squares) cells; averages of four
independent determinations. The results in
(a,c,d) represent one of three experiments
performed in duplicate; in all experiments the
phospholipid determination was performed in
duplicate (± SD); (b) shows pooled data from
four independent experiments performed in
duplicate (mean values ± SD); the p value was
calculated using Student’s t-test. Similar
experiments performed in transiently
transfected NIH-3T3 cells were less conclusive
because of the overall low expression level (see
Materials and methods).
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(p < 0.00001) constitutively elevated PI(3,4,5)-P3 content
in GM-128 cells (Fig. 2b,e). High performance liquid
chromatography (HPLC) analysis of glycerophosphoinosi-
tides prepared from GM-1 and GM-128 cells confirmed
the two-fold increase in the level of PI(3,4,5)-P3 in resting
p110CAAX transfectants (Fig. 2f). Serum stimulation
induced a similar rise in the PI(3,4,5)-P3 content of
untransfected and HA-p110CAAX-transfected GM-1 cells
(Fig. 2a). The net increase was comparable in both cell
types (Fig. 2d), but there was still a higher level of
PI(3,4,5)-P3 in cells transfected with HA-p110CAAX (Fig.
2a,c,e); this indicates that the membrane-bound
HA-p110CAAX may not be activated by serum stimula-
tion. Previous studies have shown that, upon stimulation,
only a minor fraction of the total PI 3-kinase is recruited to
the membrane [38]. Thus the (low) expression of HA-
p110CAAX correlates with the small but consistently ele-
vated levels of PI(3,4,5)-P3 in GM-128 cells. The
increment in PI(3,4,5)-P3 caused by the expression of
membrane-targeted PI 3-kinase is comparable to the
serum-stimulated PI(3,4,5)-P3 formation in parental cells,
and is presumably sufficient to activate downstream
effectors (see below).
Growth factors activate protein kinase B (PKB) in a wort-
mannin-sensitive manner; this activation correlates with the
serine and threonine phosphorylation of PKB, and can be
detected by the reduced mobility of the modified protein
in SDS–PAGE gels [20,21,39]. Western blot analysis (Fig.
3a) showed that expression of the membrane-targeted
PI 3-kinase in GM-128 cells led to the constitutive activa-
tion of PKB which resulted in its retarded migration during
electrophoresis. Figure 3a also shows that PKB was acti-
vated upon stimulation with serum, and that the activation
was repressed if the cells were treated with wortmannin.
Mutation of an arginine residue at position 916 of the con-
served kinase motif (the ATP-binding site, DRHNSN) to
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Figure 3
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Expression of membrane-targeted PI 3-kinase results in the constitutive
activation of PKB. (a) Mobility-shift assay of PKB activation. Serum-
starved GM-1 and GM-128 cells were treated for 15 min with 100 nM
wortmannin or medium, and then stimulated with 10 % FCS for 20 min.
The cells were then lysed and PKB was immunoprecipitated.
Stimulation coincided with a decreased mobility of PKB (filled
arrowheads) [39]. Wortmannin treatment inhibited both constitutive
and stimulated PKB activation. (b) PKB activity in transiently
transfected NIH-3T3 fibroblasts. NIH-3T3 cells were transfected with
wild-type HA-tagged p110a (HA-p110), HA-p110CAAX, inactive
p110a carrying a point mutation (R916P) in the ATP-binding site [40]
(HA-p110R916P) or inactive membrane-targeted p110
(HA-p110CAAXR916P). Open bars to the right show data from cells
transfected with empty vector (mock) or from untreated cells (control).
The endogenous PKB activity (mean of three independent
determinations ± SD) was slightly elevated in cells transfected with the
construct expressing wild-type p110, but markedly elevated in cells
expressing the membrane-targeted PI 3-kinase. (c) Effect of
membrane-targeted PI 3-kinase on the activation of ERK. The
activation of ERK-1 (p44) and ERK-2 (p42) results in their decreased
mobilities on SDS–PAGE [59], and is detected on western blots using
anti-ERK-1 and anti-ERK-2 antibodies. In resting (serum-starved) GM-1
cells a weak activation of both ERK-1 and ERK-2 is observed, which is
almost completely repressed in GM-128 cells. Stimulation of GM-1
cells with 10 % FCS for 5 min resulted in a marked mobility shift (filled
arrow heads) which was only marginal in the corresponding GM-128
cells. In contrast, stimulation of both GM-1 and GM-128 cells with
100 mM ATP for 2 min activates ERK-1 and ERK-2.
a proline abolishes the catalytic activity of p110a [40].
Wild-type HA-p110, HA-p110R916P, HA-p110CAAX and
HA-p110CAAXR916P constructs were transiently
expressed in NIH-3T3 fibroblasts and the effect on PKB
activity was determined. Kinase assays (Fig. 3b) proved
that transfection with catalytically active membrane-tar-
geted HA-p110CAAX caused a 4–5-fold activation of
PKB, whereas wild-type HA-p110 caused only a marginal
(2-fold) activation.
A role for PI 3-kinase in the activation of the mitogen-acti-
vated kinases ERK-1 and ERK-2 initiated by growth factors
and agonists of G-protein-coupled receptors has been dis-
cussed [33,41–43]. By contrast, in serum-stimulated and -
starved GM-128 cells, the activation of ERK-1 and ERK-2
appeared to be downregulated by the membrane-targeted
PI 3-kinase, as measured by a gel-retardation assay (Fig.
3c). This observation is in line with the recent finding that
PI(3,4,5)-P3 formation can disrupt the interaction between
p85 SH2 domains and tyrosine-phosphorylated growth
factor receptors [6]. In contrast to growth factor receptors,
G-protein-coupled receptors activate the Ras–Raf–ERK
pathway through the bg subunits of heterotrimeric G-pro-
teins [44–46]. When GM-1 cells (which express G-protein-
coupled ATP receptors at the plasma membrane; S.A.D.
and M.T., unpublished results) were stimulated with ATP,
we found that the membrane-targeted PI 3-kinase did not
interfere with ERK activation (Fig. 3c). Taken together,
these results suggest that, in the monoblastic GM-1 cells, PI
3-kinase does not activate ERKs.
Activation of the phagocyte respiratory burst by chemo-
tactic agonists is inhibited by wortmannin and requires
the assembly of the NADPH oxidase from membrane and
cytosolic components. Studies with phagocytes from
patients with chronic granulomatous disease unequivo-
cally demonstrated that, in addition to the small GTPase
Rac, p47phox and p67phox are soluble components of the
NADPH oxidase [47–49]. A role for PI 3-kinase in the
activation of Rac has been suggested [34], and it has
recently been proposed that PAK phosphorylates p47phox
[31]. It was also shown that phosphorylation of p47phox in
neutrophils stimulated with the fMet-Leu-Phe peptide is
partially sensitive to wortmannin or LY294002, another
selective inhibitor of PI 3-kinase [50]. As the monoblastic
phagocyte line GM-1 expresses p47phox, we investigated
whether the membrane-targeting of PI 3-kinase results in
the constitutive phosphorylation of p47phox. The results in
Figure 4 show that basal phosphorylation of p47phox was
enhanced in cells expressing HA-p110CAAX, and that
the enhanced phosphorylation was repressed by wort-
mannin. However, upon stimulation of phagocytes,
p47phox is phosphorylated at several sites [28]; thus the
precise role of the wortmannin-sensitive PI 3-kinase-
mediated phosphorylation of p47phox in NADPH oxidase
activation needs to be refined.
Conclusions
The role of PI 3-kinase in signal transduction is poorly
understood. Its major substrate, PI(4,5)-P2, is presumably
membrane-associated, but enzyme with high catalytic
activity is mainly localized in the cytosol in several tissues
[10,12,51]. A chimeric protein consisting of the inter-SH2
domain of p85 fused to the amino terminus of p110 appar-
ently mediates growth factor-independent signaling when
expressed in fibroblasts [5]. However, it is not clear how
this chimeric kinase is recruited to cellular membranes
and how it interacts with its presumed substrate,
PI(4,5)-P2. We have now fused the farnesylation signal of
Ha-Ras to p110 in order to position the enzyme at cellular
membranes. Targeting of PI 3-kinase to the site of its pre-
ferred substrate led to constitutive stimulus-independent
enhanced catalysis and initiated different classes of signal-
transduction pathway. Membrane targeting of PI 3-kinase
is sufficient to activate PKB, which in turn has been
shown to phosphorylate glycogen synthase kinase-3 by an
ERK-independent pathway [20]. The constitutive activa-
tion of PI 3-kinase appears to downregulate the basal
activity of ERKs, suggesting that PI(3,4,5)-P3 may have an
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Figure 4
Membrane targeting of PI 3-kinase coincides with elevated basal
phosphorylation of p47phox. Serum-starved GM-1 and GM-128 cells
were labeled with [32P]orthophosphate. Where indicated 150 nM
wortmannin (or vehicle) was added for 30 min before proteins were
precipitated with 10 % trichloroacetic acid. Immunoprecipitates of
p47phox from renatured lysates were resolved by SDS–PAGE and
blotted onto PVDF membranes; the 32P content was determined using
a PhosphorImager (Molecular Dynamics). After autoradiography, the
membranes were rehydrated and the p47phox content of each
precipitate was estimated from western blots. Results from two
independent experiments were normalized for p47phox content. Mean
values of four determinations ± SD.
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inhibitory function in this pathway. In addition, mem-
brane-targeting of PI 3-kinase implicates PI(3,4,5)-P3 in
the rapid phosphorylation of p47phox, and hence in the
physiological assembly of the NADPH oxidase.
Materials and methods
Materials
Cell culture media and antibiotics were purchased from GIBCO, Basel
Switzerland; [32P]gATP and [32P]orthophosphate were from Amersham,
UK; 17-hydroxywortmannin [10,52] was a generous gift from T. Payne.
Antibodies
Anti-p85 serum was prepared from a rabbit that was immunized with
purified recombinant human p85a (S.A.D. and M.T., unpublished
observations). Anti-HA (12CA5) was from Boehringer Mannheim,
Germany; alkaline phosphatase- and peroxidase-conjugated goat anti-
rabbit antibodies were from Bio Rad, Switzerland; anti-ERK antibodies
were from Santa Cruz Biotechnology, Santa Cruz, California, USA.
Anti-p47phox antibodies were a generous gift from O.T.G Jones.
Cell culture and transfections
The HA epitope with the amino-acid sequence YPYDVPDYASL was
added to the amino terminus of the gene encoding p110a, which was
cloned from a human aorta cDNA library (to make HA-p110); for mem-
brane targeting, the carboxyl terminus of Ha-Ras [16], NPPDES-
GPGCMSCKCVLS, was enclosed just before the stop codon (making
HA-p110CAAX). The mutation of arginine 916 to proline (R916P) was
produced by PCR-directed mutagenesis. Constructs were inserted
downstream of the strong CMV1E1-promoter in the pcDNA3 expres-
sion vector which confers G418 resistance [34,53]. GM-1 cells were
cultured in RPMI-1640 supplemented with 10 % FCS [36]. Stable
transfectants (GM-128) were obtained after electroporation of the cor-
responding vector and selection with 0.8 mg ml–1 G418. When indi-
cated, cells were starved overnight in RPMI-1640 supplemented with
0.1 % FCS. For transient transfection, 18 mg of plasmid DNA
(HA-p110, HA-p110CAAX) was added together with 50 ml lipofecta-
mine (GIBCO) in 3 ml Optimem 1 medium (GIBCO) to 106 NIH-3T3
cells plated on 10 cm dishes. After 5 h at 37 °C, 3 ml of DMEM con-
taining 20 % FCS was added and the incubation continued for 24 h.
The cells were then replated in 10 % FCS and cultured overnight. The
transfection efficiency was moderate, but similar expression levels were
found for all transfectants (about 10 % efficiency) and was estimated
from immunofluorescence and western blots. 
Cell fractionation and immunoprecipitations
Both GM-1 and NIH-3T3 cells were washed with PBS, sonicated on
ice in 2.5 ml lysis buffer (50 mM NaCl, 1 mM EDTA, 1 mM DTT, 50 mM
Tris–Cl (pH 8), complete protease inhibitors (Boehringer Mannheim)
and 100 mM PMSF) and the homogenates (more than 98 % broken
cells) were centrifuged for 10 min at 100 000 rpm (TL-100, Beckman
Instruments). Triton X-100 (1 %) was added to the supernatants, and
the crude membrane pellets were solubilized in RIPA buffer (1 % Triton
X-100, 1 % deoxycholate, 0.1 % SDS, 150 mM NaCl, 1 mM EDTA,
1 mM DTT, 20 mM Tris–Cl (pH 8) and protease inhibitors). Immunopre-
cipitations were performed as previously described [54]. Briefly, lysates
were incubated for 20 min at 4 °C with GammaBind G Sepharose
(Pharmacia). Following centrifugation, the supernatants were incubated
for 90 min at 4 °C with the appropriate antibodies and the immunocom-
plexes were recovered by adding fresh GammaBind G Sepharose
(Pharmacia) for an additional 30 min. For western blotting, the immuno-
precipitates were washed once with RIPA buffer containing
0.5 M NaCl; twice with 0.15 M NaCl, 0.5 % NP-40, 0.5 % deoxy-
cholate, 0.05 % SDS and 10 mM Tris–Cl (pH 8); and once with
0.05 % SDS and 10 mM Tris–Cl (pH 8). Western blots were per-
formed as described [54] and developed with alkaline phosphatase-
conjugated goat anti-rabbit antibodies according to the instructions
provided by the manufacturer.
Kinase assays
PI 3-kinase activity was measured in either anti-p85 (IP p85) or anti-HA
(IP HA) immunoprecipitates as described [55,56]. Briefly, immunoprecip-
itates were washed at 4 °C once with RIPA buffer; once with 0.5 M LiCl
and 0.1 M Tris–Cl (pH 8.0); twice with 150 mM NaCl, 10 mM Tris–Cl
(pH 7.6) and 1 mM EDTA; and once with 20 mM Na–Hepes (pH 7.3),
1 mM DTT and 5 mM MgCl2. Finally, the pellets were resuspended in
20 ml of a solution containing 20 mM Na–Hepes (pH 7.3), 1 mM DTT
and 5 mM MgCl2, and mixed thoroughly with 30 ml substrate solution
prepared as follows: phosphatidylinositol and phosphatidylserine (each
100 mg in CHCl3) were dried under nitrogen and the lipid film taken up in
50 ml 1 % Na–cholate (w/v) in a sonication bath and diluted with 100 ml
water, 100 ml kinase assay buffer (100 mM b-glycerophosphate, 25 mM
pyrophosphate, 150 mM NaCl, 5 mM DTT and 100 mM Na–Hepes
(pH 7.3)) and 50 ml 75 mM MgCl2. The samples were prewarmed for
5 min at 37 °C and reactions were started by adding 100 mM ATP (in
20 mM Na–Hepes (pH 7.3), 1 mM DTT and 5 mM MgCl2 containing
5 mCi [32P]gATP) and terminated after 10 min with 100 ml 1 M HCl.
Lipids were extracted with 200 ml CHCl3:CH3OH (1:1, v/v) by vortexing
for 1 min. The organic phase was washed with 80 ml 1 M HCl:CH3OH
(1:1, v/v) and dried. The lipid film was resuspended in 30 ml
CHCl3:CH3OH (2:1, v/v) and two aliquots of 5 ml were spotted onto
oxalate-impregnated silica plates (see below). PI(3)32P was determined
from the TLC plates using a PhosphorImager (Molecular Dynamics).
PKB activity was assessed in lysates of transiently transfected NIH-3T3
fibroblasts as previously described [19,20,39]. 10 cm dishes of conflu-
ent cultures were serum-starved overnight, washed twice with PBS
and lysed in 300 ml lysis buffer (50 mM Tris–Cl (pH 7.5), 1 % NP-40,
120 mM NaCl, 1 mM EDTA, 50 mM NaF, 40 mM b-glycerophosphate,
0.1 mM Na3VO4, 0.5 mM PMSF 1 mM benzamidine and 100 nM
okadaic acid). From each lysate three aliquots (100 mg protein) were
precleared with Pansorbin (Calbiochem) and the endogenous PKB
was immunoprecipitated with an affinity-purified rabbit antibody spe-
cific for the conserved carboxyl terminus (anti-RAC469–480 [19])
coupled to protein A–Sepharose (Pharmacia). Immunoprecipitates
were washed once with lysis buffer containing 0.5 M NaCl; once with
lysis buffer; and once with kinase buffer (50 mM Tris–Cl (pH 7.5),
1 mM DTT, 0.5 mM PMSF, 1 mM benzamidine and 100 nM okadaic
acid). Immunoprecipitates were resuspended in 45 ml kinase assay
buffer containing 30 mM peptide substrate (GRPRTSSFAEG derived
from glycogen synthase kinase-3 [20]), 1 mM protein kinase A inhibitor
(20-amino-acid peptide representing the active site of PKA, Bachem)
and 10 mM MgCl2. Samples were prewarmed for 5 min at 30 °C.
Reactions were initiated by the addition of 5 ml ATP (50 mM ATP con-
taining 2 mCi [32P]gATP), and terminated after 30 min with 5 ml
200 mM EDTA. From the reaction supernatants two aliquots of 20 ml
were spotted onto phosphocellulose paper, air-dried, washed four
times with 1 % phosphoric acid and subjected to Cerenkov counting.
Cell labelling and phosphorylations
Serum-starved cells (2 × 106) were labeled with 0.2 mCi ml–1
[32P]orthophosphate in 400 ml of phosphate-free RPMI-1640 in 24-well
plates for 80 min at 37 °C. Serum (50 % in phosphate-free RPMI-
1640), wortmannin (1 mM in PBS and 0.01 % DMSO) or medium alone
(total volume of the additions 100 ml) were added for the indicated
times, and the incubations were terminated with 220 ml 4.8 M HCl and
2 mM DTT. Precipitated material and culture supernatants were trans-
ferred to polypropylene tubes, diluted with 1.28 ml CH3OH and soni-
cated until all material was finely dispersed. Samples were split in half
and both aliquots were processed independently, as described else-
where [56]. Briefly, lipids were extracted by the addition of 1.28 ml
CHCl3 and vortexing for 2 min. After separation, the organic phases
were washed with 1 M HCl:CH3OH:200 mM EDTA (2:1:0.025, v/v)
and transferred to new tubes. The remaining aqueous phases were
extracted with an organic phase obtained from washing the initial
aqueous phases with 950 ml CHCl3. The organic phases were com-
bined and dried under vacuum. The lipids were dissolved in 30 ml
CHCl3:CH3OH (2:1, v/v) and two aliquots of 5 ml were spotted onto
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oxalate-impregnated silica plates (silica gel 60, Merck), that were acti-
vated at 110 °C for 40 min just before use. TLC plates were developed
in CHCl3:(CH3CH2)2O:CH3OH:CH3COOH:H20 (80:30:26:24:14, v/v)
[55] and autoradiograms quantified using a PhosphorImager (Molecular
Dynamics). The authenticity of PI(3,4,5)-P3 was verified as follows. Lipids
were scraped off the TLC plate, extracted with CHCl3:CH3OH (2:1, v/v),
dried under vacuum, and deacylated with methylamine reagent at 53 °C
for 40 min as previously described [57]. Glyceroinositides were analyzed
either by HPLC on Partisphere Sax columns [10] or by chromatography
on polyethyleneimine–cellulose TLC plates in 0.44 M HCl [58]. Stan-
dards of 3-phosphorylated (glycero)phosphoinositides were prepared
from pure PI precursors (Sigma) and phosphorylated with purified human
PI 3—kinase [10] in the presence of [32P]gATP.
HPLC analysis of deacylated phosphoinositides was performed as
follows: serum-starved cells (2 × 106) were labeled with 0.3 mCi ml–1
[32P]orthophosphate and lipids extracted as described above. Total
lipids were deacylated with 300 ml methylamine reagent at 53 °C for
40 min [57]. The resulting glyceroinositides were dissolved in 50 ml
20 mM NaH2PO4 and separated by HPLC on a Partisphere Sax
column [10]. The [32P] content of each fraction was determined by
liquid scintillation counting.
For the determination of p47phox phosphorylation, serum-starved GM-1
and GM-128 cells (2 × 107 for each condition) were labeled in 900 ml
phosphate-free RPMI-1640 with 0.5 mCi ml–1 [32P]orthophosphate for
70 min. Proteins were precipitated with trichloroacetic acid (10 % final
concentration). The pellets were washed twice with acetone, air-dried,
and solubilized in 150 ml of 1 % SDS and 20 mM Tris–Cl (pH 8.0) at
95 °C. The clear solutions were diluted with 1.5 ml of 1 % Triton X-100,
0.5 % Na-cholate, 150 mM NaCl, 1 mM EDTA, 0.1 mM Na3VO4, 20 mM
NaF and 30 mM b-glycerophosphate, and renatured as described
[54]. Immunoprecipitates of p47phox were resolved by SDS–PAGE,
blotted onto PVDF membranes and exposed to PhosphorImager
screens. After autoradiography, the membranes were rehydrated and
the p47phox in each precipitate was estimated from western blots using
peroxidase-conjugated goat anti-rabbit antibodies.
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Note added in proof
After submission of this manuscript, a related paper by Klippel et al. was
published (Klippel A, Reinhard C, Kavanaugh WM, Appell G, Escobedo M-
A, Williams LT: Membrane localization of phosphatidylinositol 3-kinase
is sufficient to activate multiple signal-transducing pathways. Mol Cell
Biol 1996, 16:4117–4127). This paper showed that the membrane local-
ization of PI 3-kinase causes constitutive elevated PI(3,4,5)-P3 levels and is
sufficient to activate multiple signal-transducing kinase pathways.
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